hexamethonium has been researched along with Air Sickness in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Qi, R | 1 |
Su, Y | 1 |
Pan, L | 1 |
Mao, Y | 1 |
Liang, L | 1 |
Dai, Z | 1 |
Wang, J | 1 |
Cai, Y | 1 |
Uchino, M | 1 |
Ishii, K | 1 |
Kuwahara, M | 1 |
Ebukuro, S | 1 |
Tsubone, H | 1 |
2 other studies available for hexamethonium and Air Sickness
Article | Year |
---|---|
Anti-cholinergics mecamylamine and scopolamine alleviate motion sickness-induced gastrointestinal symptoms through both peripheral and central actions.
Topics: Animals; Behavior, Animal; Cats; Cholinergic Antagonists; Hexamethonium; Hypothermia, Induced; Male; | 2019 |
Role of autonomic nervous system for development and suppression of motion sickness in Suncus murinus.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Atropine; Autonomic Ner | 2001 |